Black Knight, Inc. (NYSE:BKI) announced the release of its latest Originations Market Monitor report, looking at mortgage
Read More »
Black Knight, Inc. (NYSE:BKI) announced the release of its latest Originations Market Monitor report, looking at mortgage
Read More »Bristol Myers Squibb (NYSE: BMY) today announced that on December 10, 2021, its Board of Directors approved an increase in the quarterly dividend and authorized an additional multi-year share repurchase program.
Read More »Third Quarter GMV of $61.9 million, up 91.3% year-over-year — Shanghai, China, Dec. 13, 2021 (GLOBE NEWSWIRE) — Jowell Global Ltd. (“Jowell Global” or the “Company”) (NASDAQ: JWEL), one of the leading cosmetics,
Read More »(NASDAQ:DXCM) does use debt in its business. But the real question is whether this debt is making the company risky. Debt assists a business until the business has trouble paying it off, either with new capital or with free cash flow.
Read More »Philip Morris International Inc. (NYSE: PM) ("PMI") today announced that it will redeem all of its outstanding 2.625% Notes due February 18, 2022 (the "Notes") on January 18, 2022 (the "Redemption Date").
Read More »Nucor Corporation (NYSE: NUE) announced today that it has reached agreements to acquire a majority ownership position in California Steel Industries, Inc. (CSI) by purchasing a 50% equity interest from a subsidiary of Vale S.
Read More »The Chemours Company ("Chemours") (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions,
Read More »Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application
Read More »Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced the appointment of Raj Denhoy as Chief Financial Officer effective immediately.
Read More »Loxo Oncology at Lilly, a research and development group of Eli Lilly and Company (NYSE: LLY), and Foghorn Therapeutics Inc. (Nasdaq:
Read More »